2017-01-26 15:50:38 UTC

New AGA Perspectives Issue Live

Jan. 26, 2017

Read expert opinions on dysplasia surveillance in Barrett's esophagus, refractory H. pylori treatment and diversity in GI.

The newly released issue of AGA Perspectives covers the spectrum in terms of clinical practice topics and features a hot debate by Stuart Spechler, MD, and Prasad Iyer, MD, MSc, AGAF, on the use of radiofrequency ablation in Barrett's esophagus dysplasia surveillance. 

Some topics in the current magazine include a look at what's new in pouchitis by Bo Shen, MD, AGAF, an in-depth review of direct acting antiviral therapy access for HCV patients by Vincent Lo Re III MD, MSCE, and an interesting look at treating refractory Helicobacter pylori by leading expert Nimish Vakil, MD, AGAF. 

Additionally, get a sneak peek into AGA Community, our members-only networking forum, and the importance of diversity in GI through a piece penned by Darrell Gray, II, MD, MPH, on behalf of the AGA Diversity Committee. 

Have thoughts on this issue that you'd like to share? Reach out to our editor Gary Falk on Twitter or let your voice be heard in AGA Community

More on Barrett's Esophagus

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

Oct. 22, 2017

We describe a novel porcine 3-dimensional culture model that reproduces esophageal submucosal gland proliferation in vivo associated with cancer and injury.

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.